G1 Therapeutics' Grant

G1 Therapeutics raised a round of funding on September 30, 2011. Investors include National Institutes of Health.

G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of cancer. The company is advancing a pipeline of potenti…

Articles about G1 Therapeutics' Grant: